Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 3,724.34 million compared to INR 1,701.65 million a year ago. Revenue was INR 3,740.47 million compared to INR 1,755.41 million a year ago. Net income was INR 73 million compared to INR 51.08 million a year ago. Basic earnings per share from continuing operations was INR 2.88 compared to INR 2.18 a year ago. Diluted earnings per share from continuing operations was INR 2.88 compared to INR 2.18 a year ago.